Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Methodology
1.3. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
2.3. Scope Of Study
2.4. Crisis Scenario Analysis
2.5. Major Market Findings
2.5.1. Air Pollution Is A Major Cause Of Eye Diseases
2.5.2. Covid-19 Contributed To A High Number Of Dry Eye Disease Cases
2.5.3. Asian Race Is At Higher Risk Of Developing Dry Eye Disease
2.5.4. Excessive Screen Time Can Induce Dry Eye Symptoms

3. Market Dynamics
3.1. Key Drivers
3.1.1. Introduction Of Novel Diagnostic Techniques For Dry Eye Disease
3.1.2. Launch Of Promising Pipeline Products For Dry Eye Disease
3.1.3. Growing Incidence And Prevalence Of Dry Eye Among Different Age Groups
3.2. Key Restraints
3.2.1. Risk Of Side Effects
3.2.2. Substitute Therapies
3.2.3. Expensive Specialty Products And Complex Reimbursement Scenario

4. Key Analytics
4.1. Parent Market Analysis
4.2. Key Market Trends
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Growth Prospect Mapping
4.5. Market Maturity Analysis
4.6. Market Concentration Analysis
4.7. Value Chain Analysis
4.7.1. Research And Development
4.7.2. Manufacturing
4.7.3. Distributors
4.7.4. Post-Sales Monitoring

5. Market By Type
5.1. Otc
5.2. Prescription

6. Market By Product
6.1. Anti-Inflammatory Drugs
6.1.1. Cyclosporine
6.1.2. Corticosteroid
6.1.3. Other Anti-Inflammatory Drugs
6.2. Artificial Tears
6.3. Punctal Plugs
6.4. Secretagogues
6.5. Other Products

7. Market By Distribution Channel
7.1. Hospital Pharmacies
7.2. Independent Pharmacies And Drugstores
7.3. Online Pharmacies

8. Geographical Analysis
8.1. North America
8.1.1. Market Size & Estimates
8.1.2. North America Dry Eye Disease Market Drivers
8.1.3. North America Dry Eye Disease Market Challenges
8.1.4. North America Dry Eye Disease Market Regulatory Framework
8.1.5. Key Players In North America Dry Eye Disease Market
8.1.6. Country Analysis
8.1.6.1. United States
8.1.6.1.1. United States Dry Eye Disease Market Size & Opportunities
8.1.6.2. Canada
8.1.6.2.1. Canada Dry Eye Disease Market Size & Opportunities

9. Competitive Landscape
9.1. Key Strategic Developments
9.1.1. Mergers & Acquisitions
9.1.2. Product Launches & Developments
9.1.3. Partnerships & Agreements
9.1.4. Business Expansions & Divestitures
9.2. Company Profiles
9.2.1. Aft Pharmaceuticals
9.2.2. Alcon
9.2.3. Allergan Plc (Acquired By Abbvie)
9.2.4. Bausch Health Companies Inc
9.2.5. Johnson & Johnson
9.2.6. Lumenis
9.2.7. Novaliq Gmbh
9.2.8. Novartis Ag
9.2.9. Oasis Medical
9.2.10. Otsuka Pharmaceutical Co Ltd
9.2.11. Santen Pharmaceutical Co Ltd
9.2.12. Sentiss Pharma Private Limited
9.2.13. Sun Pharmaceutical Industries Ltd
9.2.14. Teva Pharmaceutical Industries Ltd
9.2.15. Visufarma



List of Figures

List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Growth Prospect Mapping For North America
Figure 4: Market Maturity Analysis
Figure 5: Market Concentration Analysis
Figure 6: Value Chain Analysis
Figure 7: North America Dry Eye Disease Market, Growth Potential, By Type, In 2022
Figure 8: North America Dry Eye Disease Market, By Otc, 2023-2032 (In $ Million)
Figure 9: North America Dry Eye Disease Market, By Prescription, 2023-2032 (In $ Million)
Figure 10: North America Dry Eye Disease Market, Growth Potential, By Product, In 2022
Figure 11: North America Dry Eye Disease Market, By Anti-Inflammatory Drugs, 2023-2032 (In $ Million)
Figure 12: North America Dry Eye Disease Market, Growth Potential, By Anti-Inflammatory Drugs, In 2022
Figure 13: North America Dry Eye Disease Market, By Cyclosporine, 2023-2032 (In $ Million)
Figure 14: North America Dry Eye Disease Market, By Corticosteroid, 2023-2032 (In $ Million)
Figure 15: North America Dry Eye Disease Market, By Other Anti-Inflammatory Drugs, 2023-2032 (In $ Million)
Figure 16: North America Dry Eye Disease Market, By Artificial Tears, 2023-2032 (In $ Million)
Figure 17: North America Dry Eye Disease Market, By Punctal Plugs, 2023-2032 (In $ Million)
Figure 18: North America Dry Eye Disease Market, By Secretagogues, 2023-2032 (In $ Million)
Figure 19: North America Dry Eye Disease Market, By Other Products, 2023-2032 (In $ Million)
Figure 20: North America Dry Eye Disease Market, Growth Potential, By Distribution Channel, In 2022
Figure 21: North America Dry Eye Disease Market, By Hospital Pharmacies, 2023-2032 (In $ Million)
Figure 22: North America Dry Eye Disease Market, By Independent Pharmacies And Drugstores, 2023-2032 (In $ Million)
Figure 23: North America Dry Eye Disease Market, By Online Pharmacies, 2023-2032 (In $ Million)
Figure 24: North America Dry Eye Disease Market, Country Outlook, 2022 & 2032 (In %)
Figure 25: United States Dry Eye Disease Market, 2023-2032 (In $ Million)
Figure 26: Canada Dry Eye Disease Market, 2023-2032 (In $ Million)

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – DRY EYE DISEASE
TABLE 2: NORTH AMERICA DRY EYE DISEASE MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: NORTH AMERICA DRY EYE DISEASE MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 4: NORTH AMERICA DRY EYE DISEASE MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: NORTH AMERICA DRY EYE DISEASE MARKET, BY PRODUCT, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: NORTH AMERICA DRY EYE DISEASE MARKET, BY ANTI-INFLAMMATORY DRUGS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: NORTH AMERICA DRY EYE DISEASE MARKET, BY ANTI-INFLAMMATORY DRUGS, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: NORTH AMERICA DRY EYE DISEASE MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: NORTH AMERICA DRY EYE DISEASE MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: NORTH AMERICA DRY EYE DISEASE MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: NORTH AMERICA DRY EYE DISEASE MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 12: NORTH AMERICA DRY EYE DISEASE MARKET REGULATORY FRAMEWORK
TABLE 13: KEY PLAYERS OPERATING IN NORTH AMERICA DRY EYE DISEASE MARKET
TABLE 14: LIST OF MERGERS & ACQUISITIONS
TABLE 15: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 16: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 17: LIST OF BUSINESS EXPANSIONS & DIVESTITURES